Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175204 | SCV000226648 | uncertain significance | not provided | 2016-05-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086861 | SCV001004579 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000175204 | SCV001856451 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321691 | SCV002609317 | likely benign | Inborn genetic diseases | 2018-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004734780 | SCV005363600 | likely benign | SCN8A-related disorder | 2024-03-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |